Mechanistic insights on lycopene usage against diabetes and associated complications
- 25 January 2025
- journal article
- review article
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 24 (1) , 57
Abstract
Lycopene is a tetraterpene compound belonging to carotenoids that are widely present in tomatoes and similar products. It is known as a powerful anti-oxidant and a non-provitamin A carotenoid. Lycopene has been found to effectively improve diabetes mellitus and its complications, such as cardiac complications, disorders caused by oxidative stress, and liver and neurological disorders. Furthermore, free radicals have been shown to disrupt the action of insulin by changing the physical state of the target cell membrane, while carotenoids improve insulin secretion and function in blood sugar regulation by neutralizing free radicals. It, therefore, seems that targeted clinical studies are needed to investigate the therapeutic effect of lycopene against metabolic disorders induced by diabetes. This review aims to summarize information on the sources and potential uses of lycopene and the possible mechanisms involved in the reduction of the above diseases. Its protective effects, in terms of toxicity and safety, are also discussed. The literature sources used in this review were PubMed, Google Scholar, Scopus, and Web of Science databases.Keywords
This publication has 89 references indexed in Scilit:
- A mechanistic review on immunomodulatory effects of selective type two cannabinoid receptor β‐caryophylleneBioFactors, 2022
- Promising effects of gingerol against toxins: A review articleBioFactors, 2021
- Personalized Cardio‐Metabolic Responses to an Anti‐Inflammatory Nutrition Intervention in Obese Adolescents: A Randomized Controlled Crossover TrialMolecular Nutrition & Food Research, 2018
- Changes on the Pancreas in Experimental Diabetes and the Effect of Lycopene on These Changes: Pdx‐1, Ngn‐3, and Nestin ExpressionsThe Anatomical Record, 2017
- Changes in the Pancreas in Experimental Diabetes and the Effect of Lycopene on These Changes: Proliferating, Apoptotic, and Estrogen Receptor α Positive CellsThe Anatomical Record, 2017
- Lycopene powers the inhibition of glycation‐induced diabetic nephropathy: A novel approach to halt the AGE‐RAGE axis menaceBioFactors, 2015
- Independent positive association of plasma β-carotene concentrations with adiponectin among non-diabetic obese subjectsEuropean Journal of Nutrition, 2014
- Effect of Lycopene Application in Rats with Experimental Diabetes Using Lipoprotein, Paraoxonase and CytokinesThe Journal of Membrane Biology, 2013
- Proinsulin C‐peptide prevents type‐1 diabetes‐induced decrease of renal Na+‐K+‐ATPase α1‐subunit in ratsDiabetes/Metabolism Research and Reviews, 2010
- Physiological dose of lycopene suppressed oxidative stress and enhanced serum levels of immunoglobulin M in patients with Type 2 diabetes mellitus: A possible role in the prevention of long-term complicationsJournal of Endocrinological Investigation, 2007